Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095

Detalles Bibliográficos
Autores principales: Rath, Suvasmita, Perikala, Venkateswarlu, Jena, Atala Bihari, Dandapat, Jagneshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136737/
https://www.ncbi.nlm.nih.gov/pubmed/37120411
http://dx.doi.org/10.1016/j.biopha.2023.114796
_version_ 1785032291132637184
author Rath, Suvasmita
Perikala, Venkateswarlu
Jena, Atala Bihari
Dandapat, Jagneshwar
author_facet Rath, Suvasmita
Perikala, Venkateswarlu
Jena, Atala Bihari
Dandapat, Jagneshwar
author_sort Rath, Suvasmita
collection PubMed
description
format Online
Article
Text
id pubmed-10136737
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-101367372023-04-28 Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095 Rath, Suvasmita Perikala, Venkateswarlu Jena, Atala Bihari Dandapat, Jagneshwar Biomed Pharmacother Article Published by Elsevier Masson SAS. 2023-07 2023-04-27 /pmc/articles/PMC10136737/ /pubmed/37120411 http://dx.doi.org/10.1016/j.biopha.2023.114796 Text en © 2023 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rath, Suvasmita
Perikala, Venkateswarlu
Jena, Atala Bihari
Dandapat, Jagneshwar
Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title_full Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title_fullStr Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title_full_unstemmed Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title_short Corrigendum to “Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs” Biomed. Pharmacother. 143 (2021) 112095
title_sort corrigendum to “factors regulating dynamics of angiotensin-converting enzyme-2 (ace2), the gateway of sars-cov-2: epigenetic modifications and therapeutic interventions by epidrugs” biomed. pharmacother. 143 (2021) 112095
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136737/
https://www.ncbi.nlm.nih.gov/pubmed/37120411
http://dx.doi.org/10.1016/j.biopha.2023.114796
work_keys_str_mv AT rathsuvasmita corrigendumtofactorsregulatingdynamicsofangiotensinconvertingenzyme2ace2thegatewayofsarscov2epigeneticmodificationsandtherapeuticinterventionsbyepidrugsbiomedpharmacother1432021112095
AT perikalavenkateswarlu corrigendumtofactorsregulatingdynamicsofangiotensinconvertingenzyme2ace2thegatewayofsarscov2epigeneticmodificationsandtherapeuticinterventionsbyepidrugsbiomedpharmacother1432021112095
AT jenaatalabihari corrigendumtofactorsregulatingdynamicsofangiotensinconvertingenzyme2ace2thegatewayofsarscov2epigeneticmodificationsandtherapeuticinterventionsbyepidrugsbiomedpharmacother1432021112095
AT dandapatjagneshwar corrigendumtofactorsregulatingdynamicsofangiotensinconvertingenzyme2ace2thegatewayofsarscov2epigeneticmodificationsandtherapeuticinterventionsbyepidrugsbiomedpharmacother1432021112095

Ejemplares similares